ICH M13A Guideline: Streamlining Bioequivalence for Oral Dosage Forms

bir ses eklendi Health

2026-11-14 17:50:24

Navigating the global regulatory landscape for generic and innovative drug development requires continuous alignment with harmonized international standards. Adopted across major regulatory authorities—including the U.S. FDA, European Medicines Agency (EMA), and Health Canada—the ICH M13A guideline establishes unified global criteria for conducting bioequivalence (BE) studies on...

0 Yorumlar 0 hisse senetleri 395 Views 0 önizleme